Patent US6080579A successfully refreshed from Google Patents.
← Back to Patent Explorer
US6080579A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for producing human intervertebral disc cells

Assignee: Carolinas Healthcare System
•
Filing: 1997-11-26
•
Granted: 2000-06-27
•
Expires: 2017-11-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is provided a method for growing human intervertebral cells. Disc tissue is surgically removed from a normal disc of a patient, the cells expanded by feeding with a cell stimulant such as a growth factor, or a cytokine or a bioactive agent to form monolayer primary cell cultures on a plastic mesh such as a nylon mesh. In the case of a growth factor, fetal bovine serum is preferred as it improves cell proliferation and production of appropriate extracellular matrix components. In another aspect of this invention, the monolayer primary cell cultures are seeded in alginate or agarose and fed again with the cell stimulant until three-dimensional cell cultures are formed. The cells are recovered from the alginate or agarose or from monolayer cultures. Re-implantation is carried out using bioresorbable carriers or cell suspensions.

Inventors

  • 👤 Edward Nathaniel Hanley, Jr.
  • 👤 Helen Elizabeth Gruber

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:34
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/0652; C12N5/0655; A; A61; A61P; A61P19/00; A61P43/00; C12N5/0068; A61K; A61K35/00; A61K35/12; A61K38/00; C12N2500/00; C12N2500/30; C12N2500/32; C12N2501/00; C12N2501/10; C12N2501/15; C12N2533/00; C12N2533/30; C12N2533/70; C12N2533/74

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 70 words
A method for propagating human intervertebral disc cells in vitro comprising: a) providing human intervertebral disc tissue; b) mincing said human intervertebral disc tissue to obtain a minced explant comprising human intervertebral disc cells; and c) culturing said minced explant under conditions to propagate and form a monolayer of human intervertebral disc cells, wherein the human intervertebral disc cells of said monolayer can be isolated and further propagated upon passaging.
Claim 2
Independent Claim 70 words
A method for propagating human intervertebral disc cells in vitro comprising: a) providing human intervertebral disc tissue; b) mincing said human intervertebral disc tissue to obtain a minced explant comprising human intervertebral disc cells; and c) culturing said minced explant under conditions to propagate and form a monolayer of human intervertebral disc cells, wherein the human intervertebral disc cells of said monolayer can be isolated and further propagated upon passaging.
Claim 3
Dependent Claim 15 words
The method of claim 1, wherein said minced explant is anchored by a plastic mesh.
Claim 4
Dependent Claim 50 words
A human intervertebral disc cell culture obtained by the method of claim 2 comprising a monolayer of human intervertebral disc cells and a human intervertebral disc minced explant, wherein at least a portion of said monolayer of human intervertebral disc cells is attached to said human intervertebral disc minced explant.
Claim 5
Dependent Claim 20 words
The method of claim 1 wherein said minced explant is cultured in the presence of serum, growth factors or cytokines.
Claim 6
Dependent Claim 18 words
The method of claim 4 wherein said minced explant is cultured in the presence of fetal bovine serum.
Claim 7
Dependent Claim 20 words
The method of claim 4 wherein said minced explant is cultured in the presence of transforming growth factor beta (TGF-β).
Claim 8
Dependent Claim 50 words
A human intervertebral disc cell culture obtained by the method of claim 1 comprising a monolayer of human intervertebral disc cells and a human intervertebral disc minced explant, wherein at least a portion of said monolayer of human intervertebral disc cells is attached to said human intervertebral disc minced explant.
Claim 9
Independent Claim 120 words
A method for culturing human intervertebral disc cells in a three-dimensional structure in vitro comprising: a) providing human intervertebral disc tissue; b) mincing said human intervertebral disc tissue to obtain a minced explant comprising human intervertebral disc cells; c) culturing said minced explant under conditions to propagate and form a monolayer of human intervertebral disc cells, wherein the human intervertebral disc cells of said monolayer can be isolated and further propagated upon passaging; d) isolating said human intervertebral disc cells from said monolayer; e) seeding the isolated cells into a carrier such that the isolated cells are dispersed and distributed in the carrier thereby forming a three-dimensional structure; and f) culturing said dispersed and distributed cells in the three-dimensional structure.
Claim 10
Independent Claim 120 words
A method for culturing human intervertebral disc cells in a three-dimensional structure in vitro comprising: a) providing human intervertebral disc tissue; b) mincing said human intervertebral disc tissue to obtain a minced explant comprising human intervertebral disc cells; c) culturing said minced explant under conditions to propagate and form a monolayer of human intervertebral disc cells, wherein the human intervertebral disc cells of said monolayer can be isolated and further propagated upon passaging; d) isolating said human intervertebral disc cells from said monolayer; e) seeding the isolated cells into a carrier such that the isolated cells are dispersed and distributed in the carrier thereby forming a three-dimensional structure; and f) culturing said dispersed and distributed cells in the three-dimensional structure.
Claim 11
Dependent Claim 16 words
The method of claim 8, wherein said three-dimensional structure is formed in a cell well insert.
Claim 12
Dependent Claim 10 words
The method of claim 8, wherein said carrier is alginate.
Claim 13
Dependent Claim 10 words
The method of claim 8, wherein said carrier is agarose.

References Cited (Backward Citations)

US4485097A Cited
US5266476A Cited
US5155034A Cited
US5496722A Cited
US5032508A Cited
US5422340A Cited
US5585116A Cited
US5256418A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-06-27 2003-12-27 2004-06-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-06-27 2007-12-27 2008-06-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-06-27 2011-12-27 2012-06-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag